BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.00%
Dow Jones
44,910.65
0.42%
Brent Oil
72.245
0.24%
Bitcoin
96,032.67
-1.26%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ultragenyx Pharmaceutical Inc (0LIF) Quote

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (0LIF)

LSE
64.79
0.00
(0.00%)
Closed December 02 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
64.79
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
64.79 52 Week Range 64.79
Market Cap
5.32B
Previous Close
64.79
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
520
Shares Outstanding
82,114,000
Dividend Yield
-
PE Ratio
-6.45
Earnings Per Share (EPS)
-7.39
Revenue
434.25M
Net Profit
-606.64M

About Ultragenyx Pharmaceutical Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ultragenyx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Ultragenyx Pharmaceutical Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0LIF. The last closing price for Ultragenyx Pharmaceutical was $64.79. Over the last year, Ultragenyx Pharmaceutical shares have traded in a share price range of $ 64.79 to $ 64.79.

Ultragenyx Pharmaceutical currently has 82,114,000 shares outstanding. The market capitalization of Ultragenyx Pharmaceutical is $5.32 billion. Ultragenyx Pharmaceutical has a price to earnings ratio (PE ratio) of -6.45.

Ask ADVFN Intelligence (AI)

0LIF Latest News

More News

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho)

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho) Evkeeza es un medicamento...

September 03 2024
UK Regulatory

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia...

January 04 2024
GlobeNewswire Inc.

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH) For the...

December 18 2023
GlobeNewswire Inc.

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH)

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH) Evkeeza è un farmaco, primo nel...

November 06 2023
GlobeNewswire Inc.

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein Evkeeza® ist das erste von der U.S. Food and Drug...

September 01 2023
GlobeNewswire Inc.

MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy

MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy NOVATO, Calif., Sept. 09, 2021 (GLOBE...

September 09 2021
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10064.7964.7964.7944164.79DE
40064.7964.7964.79118864.79DE
120064.7964.7964.7952064.79DE
260064.7964.7964.7941964.79DE
520064.7964.7964.7930764.79DE
1560064.7964.7964.7949764.79DE
2600064.7964.7964.7931364.79DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
ARBArgo Blockchain Plc
8.10p
(0.00%)
9.7M
0R0XTesla Inc
$ 339.20
(0.00%)
21.28k
0A6LGamestop Corp
$ 29.9025
(0.00%)
3.77k
0HCIAlibaba Group Holding Ltd
$ 86.90
(0.00%)
3.07k
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k

Discussion

View Full Feed
knrorrel knrorrel 11 minutes ago
Looks too $QSI - Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

November 21, 2024

Provides Update on the Company’s Innovation Roadmap & New Development Partnerships
QSI
knrorrel knrorrel 17 minutes ago
$QSI INCREASE COME https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175455634

QSI
boogeyman6757565 boogeyman6757565 19 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz4SJKAZ/call-on-blockchain-support-number-need-helpline-number?language=en_US📲
QueenMinotaur95 QueenMinotaur95 19 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Ryx2nKAB/contact-17076097626-how-do-i-contact-blockchain-support-number-easy-guide?language=en_US

https://community.geotab.com/s/question/0D5Pd00000RyxsLKAR/247-%F0%9D%95%83%F0%9D%95%9A%F0%9D%95%A7%F0%9D%95%96-support-how-do-i-contact-
Real McCoy Real McCoy 21 minutes ago
No one is interested in your shares. At all. They’re dead.
Real McCoy Real McCoy 22 minutes ago
Just trying to get to the end man.
Viking61 Viking61 25 minutes ago
Arnold has been saying the same all the way up from .40.
FNMA
knrorrel knrorrel 32 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze



QBTS
knrorrel knrorrel 33 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze

QBTS
AlwaysOptimistic AlwaysOptimistic 36 minutes ago
Great find GE. Hopefully, he can Make NioCorp Great Again!
NB
boogeyman6757565 boogeyman6757565 39 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
Krombacher Krombacher 39 minutes ago
SSC’s Endless Negativity: Let’s Address the Facts

1. Stock Performance
Yes, ERHC’s stock has declined over the years, but your constant harping on the historical decline ignores the nuance of long-term investment strategies. My positions have always been based on logical specul
ERHE
skeptical G skeptical G 41 minutes ago
was hoping for a Ravens win
IGPK
bbotcs bbotcs 47 minutes ago
Biden pardoned Hunter. Said he wouldn't, but we knew he would and he did. Who is going to pardon Joe?
bbotcs bbotcs 48 minutes ago
lj: SMCI
Bought shares at $35 and change last week. If the company survives, the purchase price will be a bargain in a year or so.
SMCI
Nrdc92 Nrdc92 49 minutes ago
That's how these cults work, Dan. The members are systematically groomed and then brainwashed, the result of which is to be unable to process facts outside the cult dogma. Here, it's even worse because the cult members have a financial stake in the cult, which provides additional incentive to remain
LWLG
nowwhat2 nowwhat2 51 minutes ago
Wooo-wooo !

https://investorshub.advfn.com/uimage/uploads/2024/12/2/evqdeLTC_111111_27_30d_chan.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/2/qrlzkltc_111111_30_30d_1pm_TL_W.jpg




https://investo
LTCUSD
Fdc4 Fdc4 1 hour ago
I would believe such from anything else but from HMBL. This is a ponzi mate, down it goes, no escape to nobody. Careful, CEO watching for more dilution space expansion
HMBL
Fdc4 Fdc4 1 hour ago
No FINRA or audit financials, I doubt this will see $0.006 again. Forget about $0.009, this is going down to trips
IGPK
Fdc4 Fdc4 1 hour ago
Now your are talking about your beliefs. Did you know your beliefs aren’t aligned with the real facts? If you want others to mind their business, keep your nonsense to yourself mate. Nobody want to hear a pumper that doesn’t have idea of what he is talking about. Chill kid
IGPK
Biotechotcguy Biotechotcguy 1 hour ago
Don't bet against the Jews. I'm in this till the end. 
DROR
sunspotter sunspotter 1 hour ago
Still howling at the moon, chazzy?

Time to admit that both HDVY and VPLM are both insider enrichment scams masquerading as wannabe patent trolls.
HDVY VPLM
Fdc4 Fdc4 1 hour ago
Good points Orca, well put
VDRM
BDEZ BDEZ 2 hours ago
No more income tax, Tariffs only. Do it

Your Recent History

LSE
0LIF
Ultragenyx Pharmaceutical
TG
9AMA
AMTD IDEA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32